Archives
-
ML365 and Postoperative Cognitive Impairment
2026-09-20
A 2024 Brain Research study found that ML365 pretreatment reduced postoperative cognitive impairment in aged mice after exploratory laparotomy, alongside lower hippocampal NLRP3 inflammasome markers and systemic oxidative stress. The work provides pharmacological evidence connecting K2P channel modulation with postoperative neuroinflammation, while leaving direct TASK1 engagement and clinical translation unresolved.
-
(-)-Blebbistatin for Mechanobiology Workflows
2026-09-19
Use (-)-Blebbistatin to transiently separate non-muscle myosin II–dependent force generation from receptor signaling, morphology, and mechanical stimulation. This workflow translates new GABAB mechanotransduction findings into practical traction-force, shear-stress, migration, and cytoskeletal assays.
-
EZH2 Inhibition Restrains SAHA-Induced SASP in SCLC
2026-09-18
The Cell Death Discovery study links SAHA-induced senescence in small cell lung cancer cells to cytoplasmic chromatin fragments, Tpr-dependent nuclear changes, and cGAS-STING activation. Its central advance is showing that EZH2 inhibition can reduce this inflammatory secretory program while strengthening SAHA-mediated growth suppression, suggesting a strategy to separate therapeutic senescence from tumor-promoting SASP.
-
Aminopeptidase Inhibitors in Cancer Therapy
2026-09-18
Hitzerd and colleagues position aminopeptidases as actionable nodes downstream of the ubiquitin–proteasome system and explain why their inhibitors may complement anticancer treatment. The review’s main practical contribution is a framework linking enzyme localization, substrate processing, inhibitor exposure, combination therapy, and resistance biology rather than treating aminopeptidase inhibition as a single-target strategy.
-
Ac-YVAD-CMK for Caspase-1 Inflammation Workflows
2026-09-17
Ac-YVAD-CMK helps separate caspase-1-dependent cytokine maturation and pyroptosis from upstream plasma-membrane injury in infection and inflammation models. This practical workflow connects Kupffer-cell TMEM16F biology with inhibitor titration, membrane-integrity measurements, cytokine profiling, and genetic controls.
-
Nitrocefin Workflows for β-Lactamase Assays
2026-09-17
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal, making it useful for resistance profiling, enzyme kinetics, and inhibitor screening. This workflow connects practical assay design with the peptide-discovery strategy reported for TEM-1 β-lactamase, helping researchers move computational hits toward experimental validation.
-
Machine-Learning Discovery of Senolytics
2026-09-16
The reference study shows that cost-effective machine-learning models trained only on published screening data can identify senolytic candidates despite small and heterogeneous datasets. Its validation of ginkgetin, periplocin, and oleandrin illustrates how computational prioritization can reduce early drug-screening costs while preserving the need for cell-type and senescence-context validation.
-
Phosphotungstic Acid Negative Stain: EM Workflow
2026-09-16
Use Phosphotungstic Acid Negative Stain Solution for rapid, high-contrast imaging of viruses, macromolecules, bacteria, and other specimens. This workflow connects structural screening with coronavirus entry research while clearly separating visible morphology from glycan-specific biochemical conclusions.
-
Selective Autophagy Tunes IRF3 and IFN Responses
2026-09-15
Wu et al. show that CALCOCO2/NDP52-mediated selective autophagy degrades IRF3 in a virus-load-dependent manner, while PSMD14 preserves basal IRF3 by removing K27-linked ubiquitin chains. The study defines a regulatory circuit that balances antiviral type I interferon production with immune suppression and clarifies how ubiquitin editing intersects with autophagic clearance.
-
Luminescent ATP Cell Viability Assay Kit I
2026-09-15
The Luminescent ATP Cell Viability Assay Kit I uses ATP-dependent firefly luciferase luminescence detection for rapid, sensitive cell viability measurement. Its reported 10 to 30,000-cell linear range and detection as early as 10 minutes support cytotoxicity, proliferation, and ferroptosis studies, while the ATP endpoint does not by itself identify a specific death mechanism.
-
(-)-JQ1: Reliable BET Negative Controls
2026-09-14
This scenario-based guide shows how (-)-JQ1 (SKU A8181) can strengthen viability, proliferation, and cytotoxicity assays by separating BET-dependent effects from solvent, handling, and nonspecific effects. It covers control selection, preparation, interpretation, and practical vendor evaluation for epigenetics research and cancer biology research.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflows
2026-09-14
Build a quantitative delivery assay that separates cellular uptake from productive translation in the same experiment. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 tracking, EGFP functional reporting, Cap1 architecture, and 5-moUTP modification for nanoparticle, electroporation, and macrophage-focused optimization.
-
Vasopressin Analogues: Evidence, Design, and Translation
2026-09-13
The reference review explains how vasopressin biology can be reshaped through receptor-selective, stability-enhancing, and longer-acting analogues. Its comparison of lypressin, desmopressin, terlipressin, and related peptides clarifies opportunities and limitations spanning diabetes insipidus, vasoconstriction research, and emerging antiviral investigation.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-12
Zhao and colleagues describe a standardized fresh whole-blood stimulation protocol that combines pathogen-relevant immune challenges with pharmacological modulation of cellular metabolism. By linking defined perturbations to cytokine outputs while preserving blood-system complexity, the method supports more reproducible cohort-scale studies of immunometabolic regulation.
-
RNA Clean and Concentrator Kit for Mitophagy Assays
2026-09-11
The RNA Clean and Concentrator Kit enables reproducible cleanup of RNA from enzymatic reactions used in mitophagy research. This article connects PINK1/Park2 assay design with practical RNA quality control, transcript standards, and workflow limitations.